RNAC Other Income/Expenses (Net)
Cartesian Therapeutics Inc · Other Income/Expenses (Net)
RNAC Other Income/Expenses (Net)
Latest reported-$62.43Mperiod ending
RNAC Other Income/Expenses (Net) ($2.52M → -$62.43M)
Annual Other Income/Expenses (Net)
High-resolution chart · PNG
RNAC other income/expenses (net) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Other Income/Expenses (Net) (USD) |
|---|---|
| -52,790,000 | |
| -33,240,000 | |
| -152,294,000 | |
| 20,232,000 | |
| -5,124,000 | |
| -12,055,000 | |
| -2,895,000 | |
| -314,000 | |
| -1,537,000 | |
| -1,540,000 | |
| 130,000 | |
| 2,519,000 |